ARS Pharmaceuticals (SPRY) Insider Trading & Ownership $10.86 -0.55 (-4.82%) (As of 01:10 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ARS Pharmaceuticals (NASDAQ:SPRY) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage40.10%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$8.92 MNumber OfInsiders Selling(Last 12 Months)9Amount OfInsider Selling(Last 12 Months)$40.39 M Get SPRY Insider Trade Alerts Want to know when executives and insiders are buying or selling ARS Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address SPRY Insider Buying and Selling by Quarter Ad Porter & CompanyI was wrong. Dead wrong. Something is stirring deep in Silicon Valley. My team and I have been watching the tech markets closely. And something BIG is about to happen.“The Final Frontier” of tech is here, click now to watch this exclusive video ARS Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/17/2024Sarina TanimotoInsiderSell100,000$11.67$1,167,000.00 12/13/2024Justin ChakmaInsiderSell27,272$12.06$328,900.32 12/12/2024Brian DorseyCOOSell25,000$12.30$307,500.00 12/10/2024Sarina TanimotoInsiderSell100,000$13.16$1,316,000.00 12/6/2024Justin ChakmaInsiderSell50,000$14.23$711,500.00 12/4/2024Laura ShawverDirectorSell14,772$13.75$203,115.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 12/3/2024Justin ChakmaInsiderSell45,000$13.19$593,550.00 12/2/2024Laura ShawverDirectorSell97,244$13.56$1,318,628.64 11/27/2024Justin ChakmaInsiderSell25,000$14.39$359,750.00 11/25/2024Justin ChakmaInsiderSell32,814$14.00$459,396.00 11/11/2024James E FlynnMajor ShareholderSell528,456$18.04$9,533,346.24 10/16/2024Kathleen D ScottCFOSell12,500$16.00$200,000.00 10/15/2024Sarina TanimotoInsiderSell100,000$14.88$1,488,000.00 10/8/2024Richard E LowenthalCEOSell100,000$13.83$1,383,000.00 9/18/2024Eric KarasInsiderSell10,000$14.00$140,000.00 9/17/2024Richard E LowenthalCEOSell100,000$12.93$1,293,000.00 8/26/2024Peter A ThompsonDirectorSell83,695$13.00$1,088,035.00 8/23/2024Peter A ThompsonDirectorSell69,500$13.03$905,585.00 8/21/2024Peter A ThompsonDirectorSell407,700$13.56$5,528,412.00 8/20/2024Brian DorseyCOOSell50,000$15.00$750,000.00 8/20/2024Kathleen D ScottCFOSell12,500$16.00$200,000.00 8/20/2024Richard E LowenthalCEOSell100,000$15.03$1,503,000.00 8/19/2024Eric KarasInsiderSell10,000$14.00$140,000.00 7/16/2024Richard E LowenthalCEOSell100,000$11.40$1,140,000.00 7/9/2024Sarina TanimotoInsiderSell100,000$9.62$962,000.00 6/12/2024Sarina TanimotoInsiderSell95,862$9.15$877,137.30 6/11/2024Richard E LowenthalCEOSell4,138$9.00$37,242.00 5/16/2024Sarina TanimotoInsiderSell89,096$9.06$807,209.76 5/15/2024Richard E LowenthalCEOSell5,147$9.05$46,580.35 5/14/2024Sarina TanimotoInsiderSell5,757$9.01$51,870.57 5/7/2024Sarina TanimotoInsiderSell100,000$9.34$934,000.00 4/16/2024Sarina TanimotoInsiderSell100,000$9.28$928,000.00 4/9/2024Richard E LowenthalCEOSell100,000$9.28$928,000.00 3/27/2024Ra Capital Management, L.P.DirectorBuy505,954$9.79$4,953,289.66 3/25/2024Ra Capital Management, L.P.DirectorBuy437,600$9.06$3,964,656.00 3/25/2024Richard E LowenthalCEOSell95,267$9.12$868,835.04 3/22/2024Sarina TanimotoInsiderSell2,343$9.02$21,133.86 3/21/2024Richard E LowenthalCEOSell472$9.00$4,248.00 3/19/2024Richard E LowenthalCEOSell1,918$9.03$17,319.54 3/15/2024Richard E LowenthalCEOSell96,756$9.14$884,349.84 Grab This Altcoin Before Trump's Crypto Announcement (Ad)Grab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which is why I'm recommending ONE coin to all investors right now. Click here to check it out now3/14/2024Sarina TanimotoInsiderSell444$9.00$3,996.00 3/13/2024Richard E LowenthalCEOSell2,800$9.00$25,200.00 2/29/2024Richard E LowenthalCEOSell3,782$9.02$34,113.64 2/28/2024Sarina TanimotoInsiderSell98,778$9.02$890,977.56 2/26/2024Sarina TanimotoInsiderSell700$9.01$6,307.00 (Data available from 1/1/2013 forward) SPRY Insider Trading Activity - Frequently Asked Questions Who is on ARS Pharmaceuticals's Insider Roster? The list of insiders at ARS Pharmaceuticals includes Alexander A Fitzpatrick, Brian Dorsey, Eric Karas, James E Flynn, Justin Chakma, Kathleen D Scott, Laura Shawver, Peter A Thompson, Ra Capital Management, L.P., Richard E Lowenthal, and Sarina Tanimoto. Learn more on insiders at SPRY. What percentage of ARS Pharmaceuticals stock is owned by insiders? 40.10% of ARS Pharmaceuticals stock is owned by insiders. Learn more on SPRY's insider holdings. Which ARS Pharmaceuticals insiders have been buying company stock? The following insiders have purchased SPRY shares in the last 24 months: Alexander A Fitzpatrick ($144,800.00), and Ra Capital Management, L.P. ($40,348,945.66). How much insider buying is happening at ARS Pharmaceuticals? Insiders have purchased a total of 7,433,554 SPRY shares in the last 24 months for a total of $40,493,745.66 bought. Which ARS Pharmaceuticals insiders have been selling company stock? The following insiders have sold SPRY shares in the last 24 months: Brian Dorsey ($1,057,500.00), Eric Karas ($280,000.00), James E Flynn ($9,533,346.24), Justin Chakma ($2,453,096.32), Kathleen D Scott ($400,000.00), Laura Shawver ($3,798,656.75), Peter A Thompson ($7,522,032.00), Richard E Lowenthal ($8,164,888.41), and Sarina Tanimoto ($9,453,632.05). How much insider selling is happening at ARS Pharmaceuticals? Insiders have sold a total of 3,435,880 ARS Pharmaceuticals shares in the last 24 months for a total of $42,663,151.77 sold. ARS Pharmaceuticals Key ExecutivesMr. Richard Lowenthal M.B.A. (Age 58)M.S., MSMSEL, Founder, President, CEO & Director Compensation: $2.75MDr. Sarina Tanimoto M.B.A. (Age 55)M.D., Co-Founder & Chief Medical Officer Compensation: $2.47MMr. Alexander A. Fitzpatrick Esq. (Age 57)Chief Legal Officer & Secretary Compensation: $677.14kDr. Robert Bell Ph.D.Co-Founder & Chief Science OfficerMs. Kathleen D. Scott CPAChief Financial Officer2 recent tradesMr. Brian T. Dorsey M.S. (Age 55)Chief Operations Officer Mr. Daniel RelovskySenior Vice President of MarketingMr. Harris Kaplan M.B.A. (Age 72)Executive Vice President of Commercial Strategy Mr. Eric Karas (Age 51)Chief Commercial Officer Compensation: $618.61k2 recent tradesMr. Justin Chakma (Age 34)Chief Business Officer & Secretary 5 recent trades More Insider Trading Tools from MarketBeat Related Companies ADMA Insider Trading SRRK Insider Trading APLS Insider Trading ACLX Insider Trading RARE Insider Trading IMVT Insider Trading OGN Insider Trading RNA Insider Trading BHVN Insider Trading VRNA Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:SPRY) was last updated on 12/26/2024 by MarketBeat.com Staff From Our PartnersThe Key to Feeding 8.1 Billion PeopleImagine a mineral so small it fits in the palm of your hand... yet its potential could transform the world's f...i2i Marketing Group, LLC | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored“AI Killer” 10x More Powerful Than ChatGPTElon Musk may be about to “kill” the world’s most powerful AI. Very few people are talking about the one AI...Paradigm Press | SponsoredElon Musk could help pay for your retirementElon Musk is the richest man in the world... And he's pouring trillions into a unique investment.Brownstone Research | SponsoredTSLA *BANG* incoming (bullet in the chamber rn)I just pinpointed 5 dirt-cheap stocks that could soar the second the shot goes off. Thanks to Donald Trump’...StocksToTrade | SponsoredBuy this Stock before Trump Takes Office!To make sure everyone has the opportunity to get in, closes for good at midnight on January 1st, we're lowerin...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARS Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ARS Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.